Psyrin
Psyrin builds AI to streamline mental healthcare by addressing the shortage of clinicians, enhancing the quality of care, and reducing provider burnout. Their AI tools act as AI employees to augment clinician capacity, aiming for a 3X reduction in per-patient workload. The company is also focused on redefining psychiatric constructs by leveraging voice as a prominent biomarker for more accurate patient-treatment matching, moving away from outdated diagnostic standards. Their vision is to create a vertical stack of AI-enabled psychiatry, aligning patient care with reimbursement incentives.
Psyrin
Psyrin builds AI to streamline mental healthcare by addressing the shortage of clinicians, enhancing the quality of care, and reducing provider burnout. Their AI tools act as AI employees to augment clinician capacity, aiming for a 3X reduction in per-patient workload. The company is also focused on redefining psychiatric constructs by leveraging voice as a prominent biomarker for more accurate patient-treatment matching, moving away from outdated diagnostic standards. Their vision is to create a vertical stack of AI-enabled psychiatry, aligning patient care with reimbursement incentives.
TL;DR
What they do: AI-driven clinical intelligence for behavioral health (product: MIRA)
Founded / HQ: Founded 2024; headquartered in San Francisco; distributed team including London
Team size: About 6 employees
Funding: Pre-Seed closed Oct 29, 2024; total funding reported ~$1.0M
Company Overview
Problem Domain
Behavioral health / psychiatry: automated assessment, monitoring, and clinical decision support for serious mental illness.
Founded
2024
Industry
Healthcare / AI (behavioral health)
Funding Track Record
Round reported with four participating investors including Concept Ventures
Investor Signal
“Early-stage venture backing with participation from seed-focused firms (2048 Ventures, Concept Ventures)”